HPM Partners »

Ocular Therapeutix shares owned by HPM Partners

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $308k 25k 12.14

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Procter & Gamble Company (PG)
Ishares Tr Core Us Aggbd Et (AGG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Ocular Therapeutix

FMR
BlackRock
Summer Road
Vanguard Group
venBio Select Advisor
Deep Track Capital
VR Adviser
TCG Crossover Management
Adage Capital Partners GP
Geode Capital Management
Alliancebernstein
State Street Corporation
Logos Global Management
Millennium Management
Paradigm Biocapital Advisors

View all funds holding Ocular Therapeutix